Prevalencia de patologías gástricas asociadas a helicobacter pylori en pacientes atendidos en el centro medico Medikal. Propuesta de medidas preventivas.
No hay miniatura disponible
Fecha
2014
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad Piloto de Odontología. Escuela de Postgrado "Dr. José Apolo Pineda".
Resumen
Las patologías gástricas han cobrado importancia como problema
de Salud Pública y no solo por su frecuencia que va en aumento,
sino por el daño que ocasiona en hombres y mujeres; muchos de
esos casos pueden ser prevenibles o detectables tempranamente.
Las personas que padecen cáncer y otras patologías como la
gastritis, tienen la oportunidad de acceder a servicios de atención
privada; sin embargo, existen serias dificultades para contar con
ayuda especializada, por parte del estado lo que es un fiel reflejo de
las condiciones aun inadecuadas para estos pacientes, por ello un
aporte importante a la salud pública sería invertir en prevención de
las patologías gástricas lo cual implicaría menor costo además que
en ciertas ocasiones se detectan muy tarde en los casos de cáncer
de estómago. El Helicobacter pylori (HP) coloniza la mucosa
gástrica y se relaciona con el desarrollo y la progresión de
enfermedades que tienen un mejor pronóstico y una evolución
favorable con la terapia de erradicación. Sin embargo existe
confusión al dar tratamiento de erradicación en patologías en las
que no está implicada esta bacteria. A continuación se evalúa las
evidencias disponibles en enfermedad ulceropéptica, cáncer
gástrico, linfoma de estómago, dispepsia, trastornos hematológicos
y reflujo gastroesofágico para determinar si es justificable o no la
búsqueda y erradicación de HP en la población latinoamericana. El
presente estudio determinó una prevalencia del 38,43 % de
patologías gástricas asociadas a Helicobacter Pylori encontrando
que no existía una propuesta de prevención por lo cual se aplicaron
medidas preventivas para disminuir estas patologías en los
pacientes atendidos en el Centro Médico Medikal durante el
periodo de enero a diciembre del 2011, siendo un estudio
descriptivo, analítico, longitudinal no experimental cuya muestra
fue de 352 los pacientes con patología gástrica asociada a
Helicobacter Pylori a quienes se aplicaron las medidas preventivas
dando un resultado del 7% de reinfección, logrando disminuir la
prevalencia de esta enfermedad.
The gastric pathologies have become important public health problem and not only for its frequency is increasing, but for the damage caused in men and women, many of these cases can be prevented or detected early. People with cancer and other diseases such as gastritis, have the opportunity to access private care services, but there are serious difficulties have specialist help from the state that is a true reflection of the conditions still inadequate for these patients, so an important contribution to public health would invest in prevention of gastric pathologies implying lower cost that sometimes also detected late in cases of stomach cancer. Helicobacter pylori (HP) colonizes the gastric mucosa and is associated with the development and progression of diseases that have a better prognosis and a favorable outcome of eradication therapy. However, there is confusion in giving eradication treatment in pathologies in which this bacterium is not involved. It then assesses the available evidence in peptic ulcer disease, gastric cancer, lymphoma of the stomach, dyspepsia, and gastroesophageal reflux haematological disorders to determine whether it is justifiable or not the pursuit and eradication of HP in the Latin American population. The present study determined a prevalence of 38.43% of diseases associated with Helicobacter pylori gastric finding that there was a proposal which is prevention by design and applied preventive measures to reduce these diseases in patients attending Medikal Medical Center during the period January to December 2011, with a descriptive, analytic, non experimental longitudinal whose sample was 352 patients with gastric disease associated with Helicobacter pylori who applied preventive measures for a result of 7% of reinfection, achieving decrease the prevalence of this disease.
The gastric pathologies have become important public health problem and not only for its frequency is increasing, but for the damage caused in men and women, many of these cases can be prevented or detected early. People with cancer and other diseases such as gastritis, have the opportunity to access private care services, but there are serious difficulties have specialist help from the state that is a true reflection of the conditions still inadequate for these patients, so an important contribution to public health would invest in prevention of gastric pathologies implying lower cost that sometimes also detected late in cases of stomach cancer. Helicobacter pylori (HP) colonizes the gastric mucosa and is associated with the development and progression of diseases that have a better prognosis and a favorable outcome of eradication therapy. However, there is confusion in giving eradication treatment in pathologies in which this bacterium is not involved. It then assesses the available evidence in peptic ulcer disease, gastric cancer, lymphoma of the stomach, dyspepsia, and gastroesophageal reflux haematological disorders to determine whether it is justifiable or not the pursuit and eradication of HP in the Latin American population. The present study determined a prevalence of 38.43% of diseases associated with Helicobacter pylori gastric finding that there was a proposal which is prevention by design and applied preventive measures to reduce these diseases in patients attending Medikal Medical Center during the period January to December 2011, with a descriptive, analytic, non experimental longitudinal whose sample was 352 patients with gastric disease associated with Helicobacter pylori who applied preventive measures for a result of 7% of reinfection, achieving decrease the prevalence of this disease.
Descripción
pdf
Palabras clave
HELICOBACTER PYLORI, PATOLOGIA ORAL, CANCER